Literature DB >> 20944810

TURP in the new century: an analytical reappraisal in light of lasers.

Assaad El-Hakim1.   

Abstract

Year:  2010        PMID: 20944810      PMCID: PMC2950762          DOI: 10.5489/cuaj.10149

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  27 in total

1.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 2.  Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Charalampos Mamoulakis; Dirk T Ubbink; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2009-07-07       Impact factor: 20.096

3.  Impact of medical therapy on transurethral resection of the prostate: a decade of change.

Authors:  C S Borth; D T Beiko; J C Nickel
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

4.  Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.

Authors:  Narmada Gupta; Rajeev Kumar; Prem N Dogra; Amlesh Seth
Journal:  BJU Int       Date:  2006-01       Impact factor: 5.588

5.  A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.

Authors:  Liam C Wilson; Peter J Gilling; Andrew Williams; Katie M Kennett; Chris M Frampton; Andre M Westenberg; Mark R Fraundorfer
Journal:  Eur Urol       Date:  2006-05-02       Impact factor: 20.096

6.  Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up.

Authors:  Richard Naspro; Nazareno Suardi; Andrea Salonia; Vincenzo Scattoni; Giorgio Guazzoni; Renzo Colombo; Andrea Cestari; Alberto Briganti; Bruno Mazzoccoli; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2006-05-02       Impact factor: 20.096

Review 7.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

8.  Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients.

Authors:  Rainer M Kuntz; Sascha Ahyai; Karin Lehrich; Amr Fayad
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

9.  Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases.

Authors:  Narihito Seki; Hiroyuki Nomura; Akito Yamaguchi; Seiji Naito
Journal:  J Endourol       Date:  2008-08       Impact factor: 2.942

10.  Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.

Authors:  Xinhua Yu; Sean P Elliott; Timothy J Wilt; A Marshall McBean
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

View more
  6 in total

1.  Effect of an employer-sponsored health and wellness program on medical cost and utilization.

Authors:  Hangsheng Liu; Katherine M Harris; Sarah Weinberger; Seth Serxner; Soeren Mattke; Ellen Exum
Journal:  Popul Health Manag       Date:  2012-07-23       Impact factor: 2.459

2.  Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia.

Authors:  Florian R Schroeck; John M Hollingsworth; Brent K Hollenbeck; Bruce L Jacobs; Anne M Suskind; Aruna V Sarma; John T Wei
Journal:  Urology       Date:  2013-03-19       Impact factor: 2.649

3.  Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a randomized clinical trial.

Authors:  Nao Sun; Yaowen Fu; Tengzheng Tian; Jialin Gao; Yuantao Wang; Song Wang; Wei An
Journal:  Int Urol Nephrol       Date:  2014-02-04       Impact factor: 2.370

4.  The effect of two weeks of treatment with dutasteride on bleeding after transurethral resection of the prostate.

Authors:  Kyu Shik Kim; Won Sik Jeong; Sung Yul Park; Yong Tae Kim; Hong Sang Moon
Journal:  World J Mens Health       Date:  2015-04-23       Impact factor: 5.400

5.  Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting.

Authors:  Maria Geitona; Pinelopi Karabela; Ioannis A Katsoulis; Hara Kousoulakou; Eleni Lyberopoulou; Eleftherios Bitros; Loukas Xaplanteris; Sotiria Papanicolaou
Journal:  BMC Urol       Date:  2014-09-26       Impact factor: 2.264

6.  Current surgical procedures for benign prostatic hyperplasia and impression of new surgical modalities.

Authors:  Abdullah M Al Khayal; Faisal K Balaraj; Turki A Alferayan; Khalid A Alrabeeah; Saad M Abumelha
Journal:  Urol Ann       Date:  2021-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.